ClinicalTrials.Veeva

Menu

Evaluation of a Protocol for Multidisciplinary Management of Acute Cholecystitis.

F

Fundacion Miguel Servet

Status

Unknown

Conditions

Acute Cholecystitis

Study type

Observational

Funder types

Other

Identifiers

NCT04543578
DIGESTIVO CHN-VBP

Details and patient eligibility

About

Acute cholecystitis is a complex disease and its management is sometimes controversial. Two main factors contribute to its complexity: the patient's surgical risk and the possibility of concomitant choledocholithiasis. The design of a multidisciplinary protocol between the services of Gastroenterology and Surgery aims to harmonize its management and to adapt it to the most recent guidelines. As it concerns more than one department, it is crucial to analyze its compliance and effectiveness.

Full description

Adult patients attending the emergency department and diagnosed with acute cholecystitis will be asked to participate. Those considered not suitable for surgery will be admitted in a medical department and assigned to conservative treatment or cholecystostomy, according to their acute cholecystitis severity. In patients suitable for surgery, risk of concomitant choledocholithiasis will be assessed and patients will be assigned to low risk or intermediate-high risk. The latter will be admitted in a medical department, and choledocholithiasis will be ruled out and treated if present. The former will be offered cholecystectomy or cholecystostomy according to their surgical risk and acute cholecystitis severity. A flowchart with extended information is attached.

PRIMARY OBJECTIVES

• To harmonize the management of acute cholecystitis with a multidisciplinary protocol based on the most recent guidelines.

SECONDARY OBJECTIVES

  • To analyze the compliance with this protocol.
  • To evaluate the validity of the criteria used in the decision-making process.
  • To assess the morbidity and mortality of different groups of patients according to the selected treatment, severity of cholecystitis and baseline characteristics of the patient.
  • To estimate the resource use in each group of patients.
  • To compare current data with a previous period.
  • To adapt and modify the protocol according the study results. INCLUSION CRITERIA
  • Patients aged 18 or older who agree to participate (an informed consent signature is required)
  • Patients attended in the emergency department of our hospital and diagnosed with acute cholecystitis according to the Tokyo criteria.

EXCLUSION CRITERIA

  • Patients under 18 years or patients who refuse to participate in the study
  • Patients diagnosed with acute cholangitis during admission for other causes.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 or older who agree to participate (an informed consent signature is required)
  • Patients attended in the emergency department of our hospital and diagnosed with acute cholecystitis according to the Tokyo criteria.

Exclusion criteria

  • Patients under 18 years or patients who refuse to participate in the study
  • Patients diagnosed with acute cholangitis during admission for other causes.

Trial design

600 participants in 4 patient groups

Patients unfit for Surgery with mild-moderate acute cholecyst
Description:
Conservative treatment (antibiotics, etc). EUS-guided gallbladder drainage will be considered in recurrent acute cholecystitis and in patients with no improvement in 48-72h after admission.
Patients unfit for Surgery with severe acute cholecystitis
Description:
Percutaneous cholecystostomy or Endoscopic Ultrasound (EUS)-guided cholecystostomy (the latter is not 24/7 available). Palliative care may also be considered in patients with very serious conditions and low life expectancy.
Patients suitable for Surgery with high and intermediate risk
Description:
Admission in Gastroenterology Department. antibiotic treatment. Close follow-up of posible AC complications. Once choledocholithiasis is solved or ruled our, the patient will be considered for same-admission cholecystectomy or programmed cholecystectomy. * High risk: Endoscopic Retrograde Cholangiopancreatography (ERCP) will be performed. * Intermediate risk: EUS or Magnetic Resonance Cholangiopancreatography prior to consider ERCP.
Patients suitable for Surgery with low risk
Description:
Admission in Surgery Department. According to the AC severity: * Mild-moderate AC: check de ASA/Charlson comorbidity index. * ASA I-II/Charlson \<6: laparoscopic cholecystectomy * ASA \> =III/Charlson \>=6: close follow-up 24-48h. Consider laparoscopic cholecystostomy (if no improvement is achieved) * Severe AC: consider Intensive Care Unit admission. Percutaneous cholecystectomy.

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Ruth Garcia Rey, MS; Federico Bolado Concejo, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems